title: Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models.
abstract: Currently, clinical gene therapy is experiencing a renaissance, with new products for clinical use approved in Europe and clinical trials for multiple diseases reporting positive results, especially those using recombinant adeno-associated viral (rAAV) vectors. Amid this new success, it is prudent to recall that the field of gene therapy experienced tragic setbacks in 1999 and 2002 because of the serious adverse events related to retroviral and adenoviral gene delivery in two clinical trials that resulted in the death of two patients. In both cases, the toxicity observed in humans had been documented to occur in animal models. However, these toxicities were either undetected or underappreciated before they arose in humans. rAAVs have been tested extensively in animals and animal models of disease, largely without adverse events, except for transient elevation in liver enzymes in some patients. However, a small but growing number of murine studies have documented that adeno-associated viral gene delivery can result in insertional mutagenesis. Herein, the aggregate data are reviewed from multiple murine studies where genotoxicity associated with rAAV treatment has been observed. The data emphasize the need for a proactive position to evaluate the potential risks and possible solutions associated with AAV-mediated gene therapy.
authors.affiliation: 1 Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health , Department of Health and Human Services, Bethesda, Maryland.
authors.forename: Randy J
authors.initials: RJ
authors.lastname: Chandler
authors.affiliation: 2 Department of Internal Medicine, Washington University School of Medicine , St. Louis, Missouri.|3 Department of Genetics, Washington University School of Medicine , St. Louis, Missouri.
authors.forename: Mark S
authors.initials: MS
authors.lastname: Sands
authors.affiliation: 1 Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health , Department of Health and Human Services, Bethesda, Maryland.
authors.forename: Charles P
authors.initials: CP
authors.lastname: Venditti
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000235:genetics*; D018014:Gene Transfer Techniques / Q000009:adverse effects*; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D051379:Mice
keywords: AAV; HCC; cancer; gene therapy; genotoxicity; insertional mutagenesis